01 / 05
Global Health Workforce Nearly Tripled Since 1990

HealthDay | Health Systems

Global Health Workforce Nearly Tripled Since 1990

“The global health workforce has expanded since 1990, mainly due to an increase in female health workers, according to a study published online Aug. 18 in The Lancet Public Health.

Megan Knight, from the Institute for Health Metrics and Evaluation in Seattle, and colleagues describe the composition and density of health workers by sex among 20 cadres for 204 countries and territories during 1990 to 2023. Overall, 1,816 country-years of data from population-based surveys, 82 from censuses, 3,888 from administrative sources, and 96 from scientific literature were used.

The researchers found there were 122.1 million health workers across 20 cadres in 2023, representing an increase of 81.2 million (198.5 percent) relative to 1990; the number included 15.1 million doctors, 33.2 million nurses, 2.4 million midwives, and 7.6 million community health workers (CHWs).”

From HealthDay.

NPR | Health Systems

US May Ease Access to Unproven Peptides

“Unproven but popular peptides touted for wellness have been available on the gray market, despite an official ban. Now, the Department of Health and Human Services is looking to bring them out of the shadows.

HHS said in a new policy that it will exercise enforcement discretion for a half dozen peptides, essentially looking the other way when they're made by small compounding pharmacies…

Peptides are strings of amino acids, shorter than proteins, that can exert powerful effects in the body. Some occur naturally and others are synthetic variations. Wellness influencers and some clinicians have promoted unproven peptides for a wide range of uses, though the evidence for their safety and effectiveness is sparse.

So even though these peptides have not been through the Food and Drug Administration's rigorous drug review and approval process, they could become easier to get.”

From NPR.

Great Ormond Street Hospital | Health Systems

Same-Day Tests Find Missed Infections in ICU Children

“Great Ormond Street Hospital (GOSH) has successfully implemented a pioneering same-day respiratory metagenomics testing service for children in intensive care, helping clinicians identify infections more quickly and make better-informed treatment decisions. The findings, published today in The Lancet Microbe, mark the first implementation of a same-day pan-microbial metagenomics service for children…

The service, developed from a pathway first established at Guy's and St Thomas' NHS Foundation Trust, was implemented at GOSH during the 2024-25 winter season. The team analysed 177 respiratory samples from 122 critically ill children and found that the technology could rapidly detect bacteria, viruses and fungi with high accuracy, while identifying infections that routine testing had missed.

Metagenomics works by sequencing all genetic material within a sample, enabling clinicians to search broadly for potential infectious causes rather than testing for a limited number of suspected pathogens. Unlike conventional diagnostic approaches, clinicians do not need to decide in advance what they are looking for.

The study found that metagenomics delivered results that altered clinical management in almost one-third (29%) of samples tested. In a quarter of cases (26%), the results influenced antimicrobial prescribing, including starting, stopping or changing antibiotics, or providing confidence that the current treatment was appropriate.

Importantly, the service detected 50 organisms that were not identified by routine diagnostic tests, all of which were subsequently confirmed by additional testing.”

From Great Ormond Street Hospital.

Axios | Health Systems

US Initiative Aims to Speed Drug Development and Reduce Costs

“The Trump administration on Wednesday is launching an effort to reimagine the way clinical trials are designed, with a goal of drastically reducing the time and money it takes to develop new drugs…

The effort — dubbed the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program — features teams selected through a bidding process that will bring drug candidates through experimental clinical trial processes…

Today, developing a drug can take longer than a decade and cost around $2 billion. More than 90% of drug candidates fail, according to HHS.”

From Axios.

Semafor | Health Systems

Ivory Coast Expands Medical Drone Service

“US drone logistics company Zipline will expand a three-year pilot program to deliver health supplies to a third of the Ivorian population over the next eight years, the latest sign that African governments are increasingly comfortable with using drones to provide social services.

The deal will see Zipline build nine more facilities in Côte d’Ivoire to add to the sole operation it has run there since 2023. After using drones to deliver nearly 4 million medical products — mainly vaccines and blood — to more than 200 healthcare centers in a region northwest of Abidjan, Zipline has now locked in a long-term contract that could serve 12 million people, roughly a third of the Ivorian population.”

From Semafor.